Premium Invest Hub
  • Investing
  • Stock
  • Latest News
  • Editor’s Pick
  • Economy
Popular Topics
  • Occupied West Bank rocked by day of violence as gunmen kill three Israeli settlers and reprisal attacks reported
  • Azerbaijan’s leader accuses Russia of passenger jet crash ‘cover up’ in blistering new attack on neighbor
  • Spanish woman killed by elephant in Thailand while bathing animal, police say
  • US adds Chinese tech giants to list of companies allegedly working with China’s military
  • Bad news for homebuyers in the Northeast and Midwest

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    Premium Invest Hub
    • Investing
    • Stock
    • Latest News
    • Editor’s Pick
    • Economy
    • Latest News

    In abortion pill arguments, Supreme Court justices seem skeptical about FDA accountability experts say

    • March 27, 2024

    The Supreme Court on Tuesday heard arguments challenging the Food and Drug Administration’s (FDA) relaxed regulations on a widely prescribed abortion pill, and while legal experts say that the case could be tossed due to a lack of standing, the justices appeared skeptical of the idea that the FDA could face no liability. 

    Erin Hawley, senior counsel for Alliance Defending Freedom, argued the case on behalf of a group of doctors challenging the FDA’s loose access restrictions on mifepristone. 

    While the justices seemed skeptical that the doctors had standing to sue, they did seem to take issue with the lack of accountability for the FDA for any harms caused by the abortion pill.  

    ‘It’s quite troubling. It’s one thing to say no one has standing in a taxpayer case where it affects everyone. Here you have the FDA who’s not publicly accountable at all really, and has continually deregulated mifepristone. So I think that will be something the court really struggles with,’ Hawley said. 

    Justice Samuel Alito at one point questioned Solicitor General Elizabeth Prelogar, arguing for the FDA. 

    ‘The statement was made that no court has ever previously second-guessed the FDA’s judgment about access to a drug,’ he said. ‘It’s never second-guessed that? Do you think the FDA is infallible?

    ‘So your argument is that it doesn’t matter if FDA flagrantly violated the law or didn’t do what it should have done, endanger the health of women,’ he said.

    ‘It’s just too bad, and nobody can sue in court?’ he pressed. 

    Thomas Jipping, senior fellow at the Heritage Foundation, said that Alito’s questioning may have revealed his thinking on who has standing in such a matter. 

    ‘If you take a view of standing that results, not in these plaintiffs cannot sue, but no one can sue, maybe your view of standing is kind of misguided in the first place.,’ he said. ‘That was an interesting one.’

    ‘Sometimes justices ask questions, not only just for an answer on a specific legal question, but kind of they ask questions that are related to a train of thought, something that they’ve been considering,’ Jipping said. 

    ‘Maybe they’ve been talking about with their clerks sort of thinking out loud. And that was clearly one, that for Justice Alito and the Chief Justice. was the significant one,’ he added. 


    This post appeared first on FOX NEWS
    Related Topics
    • Featured

    Previous Article
    • Latest News

    Biden concedes to pro-Palestinian protesters after multiple interruptions: ‘They have a point’

    • March 27, 2024
    View Post
    Next Article
    • Investing

    Hancom Scion Released on Bail in South Korean ‘Crypto Slush Fund’ Probe

    • March 27, 2024
    View Post

      Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

      Popular Topics
      • Occupied West Bank rocked by day of violence as gunmen kill three Israeli settlers and reprisal attacks reported
      • Azerbaijan’s leader accuses Russia of passenger jet crash ‘cover up’ in blistering new attack on neighbor
      • Spanish woman killed by elephant in Thailand while bathing animal, police say
      • US adds Chinese tech giants to list of companies allegedly working with China’s military
      • Bad news for homebuyers in the Northeast and Midwest
      Copyright © 2025 premiuminvesthub.com | All Rights Reserved
      • About us
      • Contact us
      • Privacy Policy
      • Terms & Conditions

      Input your search keywords and press Enter.